Ceruloplasmin activity and iron chelation treatment of patients with Parkinson’s disease

BACKGROUND: Growing body of evidence suggests that Parkinson’s disease (PD) is associated with oxidative damage via iron accumulation in the substantia nigra (SN). Low ceruloplasmin (CP)-ferroxidase activity has been identified in the SN and the cerebrospinal fluid (CSF) of patients with PD. The iro...

Descripción completa

Detalles Bibliográficos
Autores principales: Grolez, Guillaume, Moreau, Caroline, Sablonnière, Bernard, Garçon, Guillaume, Devedjian, Jean-Christophe, Meguig, Sayah, Gelé, Patrick, Delmaire, Christine, Bordet, Regis, Defebvre, Luc, Cabantchik, Ioav Z, Devos, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429376/
https://www.ncbi.nlm.nih.gov/pubmed/25943368
http://dx.doi.org/10.1186/s12883-015-0331-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429376/
https://www.ncbi.nlm.nih.gov/pubmed/25943368
http://dx.doi.org/10.1186/s12883-015-0331-3

Ejemplares similares